From Target Therapy to miRNA Therapeutics of Human Multiple Myeloma: Theoretical and Technological Issues in the Evolving Scenario

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|10|1144-1149

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.10, 2013-09, pp. : 1144-1149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 7, 2009-01 ,pp. : 854-870

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Towards MiRNA Based Therapeutics for Lung Cancer

By  

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5971-5972

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy

By  

Current Cancer Drug Targets, Vol. 18, Iss. 3, 2018-02 ,pp. : 266-277

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapy in multiple myeloma

By Avilés Agustin   Neri Natividad   Nambo M.   Cleto Sergio   Castañeda Claudia   González Martha   Talavera Alejandra   Huerta-Guzmán Judith  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 411-415

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy for Multiple Myeloma

By  

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 247-255

Bentham Science Publishers

Access to resources Recommend Favorite